BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38465549)

  • 1. Assessment of reflectance confocal microscopy for monitoring treatment of actinic keratosis and field cancerization with daylight photodynamic therapy.
    Cavalcante RBM; Valente NYS; Ferreira PS; Neto CF; Torezan L
    Eur J Dermatol; 2023 Dec; 33(6):674-679. PubMed ID: 38465549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of clinical and histologic findings in daylight photodynamic therapy for skin field cancerization: A randomized controlled four-arm study on physical methods-assisted delivery of methyl aminolevulinate.
    Bento CO; Pantaleão L; de Souza MB; Vilar EAG; Luiz RR; Filho PJS; Gismondi RAOC; Issa MCA
    Photodiagnosis Photodyn Ther; 2021 Sep; 35():102404. PubMed ID: 34133958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo confocal microscopy efficacy assessment of daylight photodynamic therapy in actinic keratosis patients.
    Seyed Jafari SM; Timchik T; Hunger RE
    Br J Dermatol; 2016 Aug; 175(2):375-81. PubMed ID: 26949030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential daylight photodynamic therapy and ingenol mebutate versus 2 sessions of daylight photodynamic therapy for the treatment of actinic keratosis: An observational, prospective, comparative study.
    Gracia-Cazaña T; Malinis AJG; Almagro-Sánchez M; Linares DP; Gilaberte Y
    Photodiagnosis Photodyn Ther; 2019 Sep; 27():34-38. PubMed ID: 31141728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo reflectance confocal microscopy for monitoring actinic keratosis treated with 5-aminolevulinic acid photodynamic therapy.
    Tan L; Zhang Y; Huang J; Tang Z; Tong X; Gao L; Zeng J
    Skin Res Technol; 2021 Sep; 27(5):871-879. PubMed ID: 33847402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conventional vs. daylight methyl aminolevulinate photodynamic therapy for actinic keratosis of the face and scalp: an intra-patient, prospective, comparison study in Italy.
    Fargnoli MC; Piccioni A; Neri L; Tambone S; Pellegrini C; Peris K
    J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1926-32. PubMed ID: 25809617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of different photoprotection strategies in preventing actinic keratosis new lesions after photodynamic therapy. The ATHENA study: a two-center, randomized, prospective, assessor-blinded pragmatic trial.
    Pavone PS; Lovati S; Scarcella G; Milani M
    Curr Med Res Opin; 2019 Jan; 35(1):141-145. PubMed ID: 30404544
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of topical piroxicam and sun filters in actinic keratosis evolution and field cancerization: a two-center, assessor-blinded, clinical, confocal microscopy and dermoscopy evaluation trial.
    Agozzino M; Russo T; Franceschini C; Mazzilli S; Garofalo V; Campione E; Bianchi L; Milani M; Argenziano G
    Curr Med Res Opin; 2019 Oct; 35(10):1785-1792. PubMed ID: 31148490
    [No Abstract]   [Full Text] [Related]  

  • 9. Daylight photodynamic therapy for severe facial and scalp actinic keratosis: a prospective non-sponsored single-centre study employing the actinic keratosis area and severity index (AKASI).
    Jordan M; Ghoreschi K; Eberle FC
    Eur J Dermatol; 2019 Feb; 29(1):67-74. PubMed ID: 30827943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single versus two-treatment schedule of methyl aminolevulinate daylight photodynamic therapy for actinic keratosis of the face and scalp: An intra-patient randomized trial.
    Gutiérrez García-Rodrigo C; Pellegrini C; Piccioni A; Tambone S; Fargnoli MC
    Photodiagnosis Photodyn Ther; 2019 Sep; 27():100-104. PubMed ID: 31141730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical, histopathological and immunohistochemical evaluation of daylight photodynamic therapy in the treatment of field cancerization: a study of 30 cases.
    Abdalla BMZ; Simas Pedreiro B; Garcia Morales A; Krutman Zveibil D; Paschoal FM
    J Dermatolog Treat; 2022 Mar; 33(2):878-884. PubMed ID: 32628053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcipotriol as pretreatment prior to daylight-mediated photodynamic therapy in patients with actinic keratosis: A case series.
    Galimberti GN
    Photodiagnosis Photodyn Ther; 2018 Mar; 21():172-175. PubMed ID: 29203353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Field cancerization treatment using topical photodynamic therapy: A comparison between two aminolevulinate derivatives.
    de Oliveira ER; Inada NM; Blanco KC; Bagnato VS; Salvio AG
    Photodiagnosis Photodyn Ther; 2020 Jun; 30():101603. PubMed ID: 31821900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daylight methyl-aminolevulinate photodynamic therapy versus ingenol mebutate for the treatment of actinic keratoses: an intraindividual comparative analysis.
    Genovese G; Fai D; Fai C; Mavilia L; Mercuri SR
    Dermatol Ther; 2016 May; 29(3):191-6. PubMed ID: 26799440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fully home-based methyl aminolevulinate daylight photodynamic therapy for actinic keratosis of the face or scalp: A real life open study.
    García-Gil MF; Gracia-Cazaña T; Cerro-Muñoz P; Bernal-Masferrer L; Navarro-Bielsa A; Gilaberte Y
    Dermatol Ther; 2022 Nov; 35(11):e15879. PubMed ID: 36184916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Home- vs clinic-based daylight photodynamic therapy with 5-aminolevulinic acid nanoemulsion (BF-200 ALA) for actinic keratosis: A randomized, single-blind, prospective study.
    Saenz-Guirado S; Ayen-Rodriguez A; Galvez-Moreno M; Velasco-Amador JP; Llamas-Molina JM; Ruiz-Villaverde R; Molina-Leyva A
    Photodiagnosis Photodyn Ther; 2024 Apr; 46():104031. PubMed ID: 38438001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daylight photodynamic therapy is an option for the treatment of actinic keratosis in patients with xeroderma pigmentosum in Africa.
    Fernández-Guarino M; Mavura D; Fernández-González P; Chapa P; Ravazzano C; Jaén L; Rios L; Jaén P; Grossman H
    Photodiagnosis Photodyn Ther; 2020 Mar; 29():101631. PubMed ID: 31904551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daylight photodynamic therapy with methyl aminolevulinate cream is as effective as conventional photodynamic therapy with blue light in the treatment of actinic keratosis: a controlled randomized intra-individual study.
    Assikar S; Labrunie A; Kerob D; Couraud A; Bédane C
    J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):1730-1735. PubMed ID: 31955461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial.
    Rubel DM; Spelman L; Murrell DF; See JA; Hewitt D; Foley P; Bosc C; Kerob D; Kerrouche N; Wulf HC; Shumack S
    Br J Dermatol; 2014 Nov; 171(5):1164-71. PubMed ID: 24861492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-level light-assisted photodynamic therapy using a wearable cap-like device for the treatment of actinic keratosis of the scalp.
    Fonda-Pascual P; Alegre-Sánchez A; Harto-Castaño A; Moreno-Arrones OM; Pérez-García B; González-Morales ML; Pindado-Ortega C; Gilaberte-Calzada Y; Aguilera J; Jaen-Olasolo P; Fernández-Guarino M
    Photodiagnosis Photodyn Ther; 2019 Mar; 25():136-141. PubMed ID: 30508663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.